QR-Code

Systematic assessment of HER2 status in ductal carcinoma in situ of the breast: a perspective on the potential clinical relevance

Abstract In many countries, hormone receptor status assessment of ductal carcinoma in situ (DCIS) is routinely performed, as hormone receptor-positive DCIS patients are eligible for adjuvant anti-hormonal treatment, aiming to reduce the ipsilateral and contralateral breast cancer risk. Although HER2...

Ausführliche Beschreibung

Gespeichert in:
Hauptverfasser: Mieke R. Van Bockstal, Jelle Wesseling, Ester H. Lips, Marjolein Smidt, Christine Galant, Carolien H. M. van Deurzen
Format: Artigo
Sprache:Inglês
Veröffentlicht: BMC 2024-08-01
Schriftenreihe:Breast Cancer Research
Schlagworte:
Ductal carcinoma in situ
HER2
Immunohistochemistry
Breast
Grade
Hormone receptor status
Online-Zugang:https://doi.org/10.1186/s13058-024-01875-w
Tags: Tag hinzufügen
Keine Tags, Fügen Sie das erste Tag hinzu!

Ähnliche Einträge